Zimmer Biomet Holdings EMEA — Cost of Goods Sold decreased by 0.6% to $186.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.4%, from $165.80M to $186.40M. Over 3 years (FY 2022 to FY 2025), EMEA — Cost of Goods Sold shows an upward trend with a 7.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A lower ratio relative to revenue indicates improved manufacturing efficiency or favorable product mix.
The direct costs associated with manufacturing and delivering orthopedic products and services within the EMEA segment....
Standard metric for assessing regional gross margin performance in manufacturing sectors.
zbh_segment_emea_cost_of_goods_and_services_sold| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $137.60M | $137.60M | $137.60M | $137.60M | $135.45M | $135.45M | $135.45M | $135.45M | $154.80M | $150.70M | $132.50M | $150.90M | $165.80M | $169.80M | $160.30M | $187.50M | $186.40M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -1.6% | +0.0% | +0.0% | +0.0% | +14.3% | -2.6% | -12.1% | +13.9% | +9.9% | +2.4% | -5.6% | +17.0% | -0.6% |
| YoY Change | — | — | — | — | -1.6% | -1.6% | -1.6% | -1.6% | +14.3% | +11.3% | -2.2% | +11.4% | +7.1% | +12.7% | +21.0% | +24.3% | +12.4% |